BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17028772)

  • 21. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
    Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
    Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
    Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node.
    Farshid G; Pradhan M; Kollias J; Gill PG
    Breast; 2004 Dec; 13(6):494-501. PubMed ID: 15563857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
    Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
    J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy.
    Leidenius M; Vaalavirta L; Heikkilä P; von Smitten K; Salmenkivi K
    J Surg Oncol; 2008 Jul; 98(1):21-6. PubMed ID: 18484087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sentinel lymph node biopsy in breast cancer].
    Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R
    Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.
    Karam AK; Hsu M; Patil S; Stempel M; Traina TA; Ho AY; Cody HS; Port ER; Morrow M; Gemignani ML
    Ann Surg Oncol; 2009 Jul; 16(7):1952-8. PubMed ID: 19381724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of nonsentinel lymph node metastasis in sentinel node-positive breast carcinoma.
    Kapur U; Rubinas T; Ghai R; Sinacore J; Yao K; Rajan PB
    Ann Diagn Pathol; 2007 Feb; 11(1):10-2. PubMed ID: 17240301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    Majid S; Rydén L; Manjer J
    BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
    Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.
    Cserni G; Bianchi S; Vezzosi V; Arisio R; Bori R; Peterse JL; Sapino A; Drijkoningen M; Kulka J; Eusebi V; Foschini MP; Bellocq JP; Marin C; Thorstenson S; Amendoeira I; Reiner-Concin A; Decker T
    Eur J Cancer; 2007 Jun; 43(9):1407-14. PubMed ID: 17531465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
    Gauthier T; Fermeaux V; Mollard J; Aubard Y
    Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast sentinel lymph node dissection before preoperative chemotherapy.
    Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
    Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node.
    Van den Eynden GG; Vandenberghe MK; van Dam PJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5391-7. PubMed ID: 17875768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for non-sentinel lymph node metastases in breast cancer patients with positive sentinel lymph nodes.
    Zhang T; Wang H; Chen BP; Zhang HS; Wei XL; Fu Y; Li Z; Hu GK
    Chin Med J (Engl); 2008 Oct; 121(20):2107-9. PubMed ID: 19080285
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement?
    van Deurzen CH; Bult P; de Boer M; Koelemij R; van Hillegersberg R; Tjan-Heijnen VC; Hobbelink MG; de Bruin PC; van Diest PJ
    Am J Surg Pathol; 2009 Jan; 33(1):106-10. PubMed ID: 18852675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections?
    Samoilova E; Davis JT; Hinson J; Brill YM; Cibull ML; McGrath P; Romond E; Moore A; Samayoa LM
    Ann Surg Oncol; 2007 Aug; 14(8):2221-7. PubMed ID: 17549569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.